Walter Riesen
Impact in
-
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Hormonal Regulation and Hypertension
- Nephrology top 1%
- Gout, Hyperuricemia, Uric Acid
Papers in
-
- Diabetes, Cardiovascular Risks, and Lipoproteins 21
- Hormonal Regulation and Hypertension 8
-
- Blood Pressure and Hypertension Studies 14
- Co-authors
- P WeidmannPascal BovetFred PaccaudConrad F. ShamlayeR MordasiniPaolo FerrariVincent WietlisbachMichel Burnier
- Journals
- Journal of Molecular Medicine (6 papers)European Journal of Clinical Pharmacology (6 papers)Atherosclerosis (5 papers)European Journal of Clinical Investigation (5 papers)BMC Public Health (5 papers)
- Partner nations
- SwitzerlandSeychellesUnited States
In The Last Decade
Walter Riesen
130 papers receiving 3.3k citations
Peers
Comparison fields: 5 of 132
- Endocrinology, Diabetes and Metabolism 1.1k
- Nephrology 464
- Cardiology and Cardiovascular Medicine 952
- Pharmacology 447
- Emergency Medicine 251
Countries citing papers authored by Walter Riesen
This map shows the geographic impact of Walter Riesen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Walter Riesen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Walter Riesen more than expected).
Fields of papers citing papers by Walter Riesen
This network shows the impact of papers produced by Walter Riesen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Walter Riesen. The network helps show where Walter Riesen may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Walter Riesen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2019 | 36 | |
| 3 | 2017 | 0 | |
| 4 | 2017 | 16 | |
| 5 | 2011 | 3 | |
| 6 | 2010 | 2 | |
| 7 | 2005 | 16 | |
| 8 | 2004 | 270 | |
| 9 | 2003 | 196 | |
| 10 | [Evaluating the efficacy and tolerance of atorvastatin in hyperlipidemia in general practice (SWITCH Study)]. | 2000 | 6 |
| 11 | 2000 | 7 | |
| 12 | 1999 | 12 | |
| 13 | 1997 | 74 | |
| 14 | 1995 | 3 | |
| 15 | 1994 | 8 | |
| 16 | 1992 | 32 | |
| 17 | 1991 | 54 | |
| 18 | 1989 | 4 | |
| 19 | [The effect of lipid level lowering diets on bile lipids and plasma lipoproteins in normal persons]. | 1979 | 5 |
| 20 | [A new method for the determination and characterization of monoclonal immunoglobulins (double line method)]. | 1971 | 5 |
About Walter Riesen
Walter Riesen is a scholar working on Endocrinology, Diabetes and Metabolism, Cardiology and Cardiovascular Medicine, Nephrology, Pharmacology and Cancer Research, having authored 133 papers that have together received 3.6k indexed citations. Recurring topics across this work include Lipoproteins and Cardiovascular Health (24 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (21 papers), Pharmacology and Obesity Treatment (14 papers), Blood Pressure and Hypertension Studies (14 papers), Cancer, Lipids, and Metabolism (12 papers), Diet and metabolism studies (9 papers), Hormonal Regulation and Hypertension (8 papers) and Monoclonal and Polyclonal Antibodies Research (8 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (1.1k citations), Nephrology (464 citations), Cardiology and Cardiovascular Medicine (952 citations), Pharmacology (447 citations) and Emergency Medicine (251 citations). Walter Riesen has collaborated with scholars based in Switzerland, Seychelles and United States. Frequent co-authors include P Weidmann, Pascal Bovet, Fred Paccaud, Conrad F. Shamlaye, R Mordasini, Paolo Ferrari, Vincent Wietlisbach, Michel Burnier, David Conen and Roger Darioli. Their work appears in journals such as Journal of Molecular Medicine, European Journal of Clinical Pharmacology, Atherosclerosis, European Journal of Clinical Investigation and BMC Public Health.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.